Hello, everyone, and how are you today? We hope the weekend was invigorating, if not relaxing, given all the news coming from the American Society of Clinical Oncology meeting. In fact, many of the tidbits listed below reflect the flurry of study results that were released. In any event, another busy day is on the way, so please join us as we brew a cup of stimulation and dig in for several rounds of deadlines, meetings and research. Hope your day goes well and drop us a line if you come across anything interesting...
ASCO Stocks Winners And Losers (The Street)
Greece Hurts Pharma With Or Without The Euro (Bloomberg News)
Glaxo Melanoma Drugs Beat Standard Chemo In Studies (Bloomberg News)
Amylin Attracts Bids From AstraZeneca And Bristol (Reuters)
UK Looks To Clear Water Supply Of Contraceptives (The Guardian)
Taxol Beat Newer Drugs In Breast Cancer Study (MedPage Today)
Ariad Leukemia Drugs Helps Chronic Patients In Trial (Reuters)
Bayer Cancer Drug Stalls Stomach Tumors After Usual Treatment (Bloomberg News)
Avastin As A Follow-Up Helped Colon Cancer Patients (Reuters)
EDITOR'S NOTE: Please check this post for updates during the day
rain pic thx to sterlic on flickr